Protagonist Therapeutics Inc (NASDAQ:PTGX)

7.32
BATS BZX Real-Time Price
As of 3:39pm ET
 -0.03 / -0.41%
Today’s Change
5.49
Today|||52-Week Range
23.97
+8.77%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Protagonist Therapeutics Inc have a median target of 15.00, with a high estimate of 18.00 and a low estimate of 11.00. The median estimate represents a +104.92% increase from the last price of 7.32.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Protagonist Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.45
Sales
$5.6M
Reporting Date
Mar 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -52.88%
 
 
 
 
 
 
Growthannually 21.05%
 
 
 
 

Sales

Growthquarterly -7.91%
 
 
 
 
 
 
Growthannually 70.73%
 
 
 
 
Key to the earnings and sales forecast charts.